AK Medical Holdings Limited (HKG:1789)

Hong Kong · Delayed Price · Currency is HKD

5.51

+0.05 (0.92%)

Jul 31, 2026, 4:08 PM HKT

-21.06% (1Y)

Market Cap	5.96B -23.9%
Revenue (ttm)	1.65B +10.1%
Net Income	377.35M +23.8%
EPS	0.34 +24.2%
Shares Out	1.08B
PE Ratio	16.34
Forward PE	13.33
Dividend	0.12 (2.14%)
Ex-Dividend Date	Jun 23, 2026

Volume	2,558,000
Open	5.38
Previous Close	5.46
Day's Range	5.32 - 5.57
52-Week Range	4.75 - 7.15
Beta	-0.39
Analysts	Strong Buy
Price Target	8.06 (+46.28%)
Earnings Date	Aug 26, 2026

About AK Medical Holdings

AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products in the People’s Republic of China, the United Kingdom, and internationally. It offers knee, hip, and spinal and trauma replacement implants; and 3D-printed products, such as 3D-printed hip and knee replacement implants, 3D-printed spinal and trauma implants, as well as customized joint, pelvic, spinal and trauma implant products and customized value-added surgical services and orthopedic surgical ro... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2003

Employees 983

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 1789

Full Company Profile

Financial Performance

In 2025, AK Medical Holdings's revenue was 1.48 billion, an increase of 10.11% compared to the previous year's 1.35 billion. Earnings were 339.09 million, an increase of 23.79%.

Financial numbers in CNY Financial Statements

Analyst Summary

According to 6 analysts, the average rating for 1789 stock is "Strong Buy." The 12-month stock price target is $8.06, which is an increase of 46.28% from the latest price.

Price Target

$8.06

(46.28% upside)

Analyst Consensus: Strong Buy

Stock Forecasts